Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 60

1.

Updates on Osteoimmunology: What's New on the Cross-Talk Between Bone and Immune System.

Ponzetti M, Rucci N.

Front Endocrinol (Lausanne). 2019 Apr 18;10:236. doi: 10.3389/fendo.2019.00236. eCollection 2019. Review.

2.

Isolation and Generation of Osteoclasts.

Rucci N, Zallone A, Teti A.

Methods Mol Biol. 2019;1914:3-19. doi: 10.1007/978-1-4939-8997-3_1.

PMID:
30729457
3.

Bone Metastasis Pain, from the Bench to the Bedside.

Aielli F, Ponzetti M, Rucci N.

Int J Mol Sci. 2019 Jan 11;20(2). pii: E280. doi: 10.3390/ijms20020280. Review.

4.

Apoptosis-associated speck-like protein containing a caspase-1 recruitment domain (ASC) contributes to osteoblast differentiation and osteogenesis.

Sartoretto S, Gemini-Piperni S, da Silva RA, Calasans MD, Rucci N, Pires Dos Santos TM, Lima IBC, Rossi AM, Alves G, Granjeiro JM, Teti A, Zambuzzi WF.

J Cell Physiol. 2019 Apr;234(4):4140-4153. doi: 10.1002/jcp.27226. Epub 2018 Aug 31.

PMID:
30171612
5.

The Osteoclast in Bone Metastasis: Player and Target.

Maurizi A, Rucci N.

Cancers (Basel). 2018 Jun 27;10(7). pii: E218. doi: 10.3390/cancers10070218. Review.

6.

Regulation of breast cancer induced bone disease by cancer-specific IKKβ.

Marino S, Bishop RT, Capulli M, Sophocleous A, Logan JG, Mollat P, Mognetti B, Ventura L, Sims AH, Rucci N, Ralston SH, Idris AI.

Oncotarget. 2018 Mar 23;9(22):16134-16148. doi: 10.18632/oncotarget.24743. eCollection 2018 Mar 23.

7.

RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development.

Maurizi A, Capulli M, Patel R, Curle A, Rucci N, Teti A.

Bone. 2018 May;110:343-354. doi: 10.1016/j.bone.2018.02.031. Epub 2018 Mar 6.

PMID:
29501587
8.

A Complex Role for Lipocalin 2 in Bone Metabolism: Global Ablation in Mice Induces Osteopenia Caused by an Altered Energy Metabolism.

Capulli M, Ponzetti M, Maurizi A, Gemini-Piperni S, Berger T, Mak TW, Teti A, Rucci N.

J Bone Miner Res. 2018 Jun;33(6):1141-1153. doi: 10.1002/jbmr.3406. Epub 2018 Mar 24.

PMID:
29444358
9.

TRAF2 in osteotropic breast cancer cells enhances skeletal tumour growth and promotes osteolysis.

Peramuhendige P, Marino S, Bishop RT, de Ridder D, Khogeer A, Baldini I, Capulli M, Rucci N, Idris AI.

Sci Rep. 2018 Jan 8;8(1):39. doi: 10.1038/s41598-017-18327-5.

10.

Osteomimicry: How the Seed Grows in the Soil.

Rucci N, Teti A.

Calcif Tissue Int. 2018 Feb;102(2):131-140. doi: 10.1007/s00223-017-0365-1. Epub 2017 Nov 16. Review.

PMID:
29147721
11.

Osteoblast-Derived Extracellular Vesicles Are Biological Tools for the Delivery of Active Molecules to Bone.

Cappariello A, Loftus A, Muraca M, Maurizi A, Rucci N, Teti A.

J Bone Miner Res. 2018 Mar;33(3):517-533. doi: 10.1002/jbmr.3332. Epub 2017 Dec 11.

12.

Intratumoral acidosis fosters cancer-induced bone pain through the activation of the mesenchymal tumor-associated stroma in bone metastasis from breast carcinoma.

Di Pompo G, Lemma S, Canti L, Rucci N, Ponzetti M, Errani C, Donati DM, Russell S, Gillies R, Chano T, Baldini N, Avnet S.

Oncotarget. 2017 Apr 13;8(33):54478-54496. doi: 10.18632/oncotarget.17091. eCollection 2017 Aug 15.

13.

Non-conventional role of haemoglobin beta in breast malignancy.

Ponzetti M, Capulli M, Angelucci A, Ventura L, Monache SD, Mercurio C, Calgani A, Sanità P, Teti A, Rucci N.

Br J Cancer. 2017 Sep 26;117(7):994-1006. doi: 10.1038/bjc.2017.247. Epub 2017 Aug 3.

14.

Murine models of breast cancer bone metastasis.

Wright LE, Ottewell PD, Rucci N, Peyruchaud O, Pagnotti GM, Chiechi A, Buijs JT, Sterling JA.

Bonekey Rep. 2016 May 11;5:804. eCollection 2016.

15.

Interleukin-1β, lipocalin 2 and nitric oxide synthase 2 are mechano-responsive mediators of mouse and human endothelial cell-osteoblast crosstalk.

Veeriah V, Zanniti A, Paone R, Chatterjee S, Rucci N, Teti A, Capulli M.

Sci Rep. 2016 Jul 19;6:29880. doi: 10.1038/srep29880.

16.

The "soft" side of the bone: unveiling its endocrine functions.

Cappariello A, Ponzetti M, Rucci N.

Horm Mol Biol Clin Investig. 2016 Oct 1;28(1):5-20. doi: 10.1515/hmbci-2016-0009. Review.

PMID:
27107839
17.

The "love-hate" relationship between osteoclasts and bone matrix.

Rucci N, Teti A.

Matrix Biol. 2016 May-Jul;52-54:176-190. doi: 10.1016/j.matbio.2016.02.009. Epub 2016 Feb 26. Review.

PMID:
26921625
18.

Anabolic and Antiresorptive Modulation of Bone Homeostasis by the Epigenetic Modulator Sulforaphane, a Naturally Occurring Isothiocyanate.

Thaler R, Maurizi A, Roschger P, Sturmlechner I, Khani F, Spitzer S, Rumpler M, Zwerina J, Karlic H, Dudakovic A, Klaushofer K, Teti A, Rucci N, Varga F, van Wijnen AJ.

J Biol Chem. 2016 Mar 25;291(13):6754-71. doi: 10.1074/jbc.M115.678235. Epub 2016 Jan 12.

19.

Effective Small Interfering RNA Therapy to Treat CLCN7-dependent Autosomal Dominant Osteopetrosis Type 2.

Capulli M, Maurizi A, Ventura L, Rucci N, Teti A.

Mol Ther Nucleic Acids. 2015 Sep 1;4:e248. doi: 10.1038/mtna.2015.21.

20.

Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation.

Cappariello A, Paone R, Maurizi A, Capulli M, Rucci N, Muraca M, Teti A.

Biomaterials. 2015 Apr;46:58-69. doi: 10.1016/j.biomaterials.2014.12.033. Epub 2015 Jan 17.

Supplemental Content

Loading ...
Support Center